PAR 2.50% 19.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4345

  1. 875 Posts.
    lightbulb Created with Sketch. 217
    @bobsee @the buck
    Spot on. The amount of knee arthroscopies or "clean outs" prior to eventual TKRs that go on in private land in Australia is crazy, I can only imagine in the USA it is the same but worse. Whilst not a threat to getting approval, I also think the effect of weight loss drugs on PARs addressable market has been ignored.

    Anyhow for whatever reason I have a renewed sense of optimism this week. The funding situation forever baffles me and will continue to do so, but I just can't see that provided we get 2mg twice weekly approval, this doesn't get through to a NDA one way or another.
    Last edited by Duke2: 30/07/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $68.29M
Open High Low Value Volume
20.0¢ 21.0¢ 19.5¢ $189.9K 940.0K

Buyers (Bids)

No. Vol. Price($)
5 436602 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 332703 5
View Market Depth
Last trade - 16.10pm 08/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.